Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23374149)

1.

Comments on 'high versus low radioiodine activity in patients with differentiated thyroid cancer: a meta-analysis'.

Qu K, Gao P, Si R.

Acta Oncol. 2013 Aug;52(6):1238-9. doi: 10.3109/0284186X.2013.764012. Epub 2013 Feb 4. No abstract available.

PMID:
23374149
2.

High versus low radioiodine activity in patients with differentiated thyroid cancer: a meta-analysis.

Valachis A, Nearchou A.

Acta Oncol. 2013 Aug;52(6):1055-61. doi: 10.3109/0284186X.2012.742959. Epub 2012 Nov 29. Review.

PMID:
23193961
3.

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.

Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, Nicol A, Clark PM, Farnell K, McCready R, Smellie J, Franklyn JA, John R, Nutting CM, Newbold K, Lemon C, Gerrard G, Abdel-Hamid A, Hardman J, Macias E, Roques T, Whitaker S, Vijayan R, Alvarez P, Beare S, Forsyth S, Kadalayil L, Hackshaw A.

N Engl J Med. 2012 May 3;366(18):1674-85. doi: 10.1056/NEJMoa1109589.

4.
5.

Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial.

Fallahi B, Beiki D, Takavar A, Fard-Esfahani A, Gilani KA, Saghari M, Eftekhari M.

Nucl Med Commun. 2012 Mar;33(3):275-82. doi: 10.1097/MNM.0b013e32834e306a.

PMID:
22124360
6.

Radioiodine ablation for differentiated thyroid cancer-none, one dose or two?

Rees GJ.

Clin Oncol (R Coll Radiol). 2010 Mar;22(2):131-5. doi: 10.1016/j.clon.2009.11.005. Epub 2009 Dec 6.

PMID:
19969444
7.

Low-dose and high-dose radioiodine in thyroid cancer.

Ryo UY.

Am J Med. 1977 Jul;63(1):167-8. No abstract available.

PMID:
879192
8.

Dosimetry and thyroid cancer: the individual dosage of radioiodine.

Lassmann M, Reiners C, Luster M.

Endocr Relat Cancer. 2010 Jun 3;17(3):R161-72. doi: 10.1677/ERC-10-0071. Print 2010 Sep. Review.

9.

Radioiodine ablation in low-risk thyroid cancer.

Gerard SK, Park HM.

N Engl J Med. 2012 Aug 16;367(7):673; author reply 674. doi: 10.1056/NEJMc1206712#SA3. No abstract available.

PMID:
22894584
10.

Radioiodine ablation in low-risk thyroid cancer.

Loo SW.

N Engl J Med. 2012 Aug 16;367(7):672-3; author reply 674. doi: 10.1056/NEJMc1206712#SA2. No abstract available.

PMID:
22894583
11.

[Pregnancy after treatment with 131 radioiodine in women with differentiated thyroid carcinoma].

Matsumura LK.

Arq Bras Endocrinol Metabol. 2007 Jun;51(4):507-8. Portuguese. No abstract available.

12.

Radioiodine ablation in low-risk thyroid cancer.

Orlov S, Freeman JL, Walfish PG.

N Engl J Med. 2012 Aug 16;367(7):672; author reply 673-5. doi: 10.1056/NEJMc1206712#SA1. No abstract available.

PMID:
22894582
13.

Cumulative doses of radioiodine in the treatment of differentiated thyroid carcinoma: knowing when to stop.

Martins-Filho R, Ward LS, Amorim BJ, Santos AO, Lima MC, Ramos CD, Matos PS, Assumpção LV, Camargo EE, Etchebehere EC.

Arq Bras Endocrinol Metabol. 2010 Dec;54(9):807-12.

14.

Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer.

Caglar M, Bozkurt FM, Akca CK, Vargol SE, Bayraktar M, Ugur O, Karaağaoğlu E.

Nucl Med Commun. 2012 Mar;33(3):268-74. doi: 10.1097/MNM.0b013e32834ec5d6.

PMID:
22205241
15.

Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.

Bohuslavizki KH, Klutmann S, Bleckmann C, Brenner W, Lassmann S, Mester J, Henze E, Clausen M.

Strahlenther Onkol. 1999 Feb;175(2):57-61.

PMID:
10065139
16.

Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.

Bohuslavizki KH, Brenner W, Klutmann S, Hübner RH, Lassmann S, Feyerabend B, Lüttges J, Tinnemeyer S, Clausen M, Henze E.

J Nucl Med. 1998 Jul;39(7):1237-42.

17.

Radioiodine for thyroid cancer--is less more?

Alexander EK, Larsen PR.

N Engl J Med. 2012 May 3;366(18):1732-3. doi: 10.1056/NEJMe1202172. No abstract available.

PMID:
22551133
18.

Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy.

Verkooijen RB, Stokkel MP, Smit JW, Pauwels EK.

Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):499-506. Epub 2004 Jan 14.

PMID:
14722676
19.
20.

Radioiodine and thyroid cancer: some questions, controversies, and considerations.

Daniels GH.

Endocr Pract. 2001 Jul-Aug;7(4):320-3. Review. No abstract available.

PMID:
11497485
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk